Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Filippo Natali"'
Autor:
Margherita Nannini, Andrea Repaci, Gianluca Ricco, Manuela Ianni, Arber Golemi, Vincenzo Maiolo, Marco Ferrari, Filippo Natali, Elisa Lodi Rizzini, Fabio Monari, Erica Solaroli, Antonio De Leo, Thais Maloberti, Maria A. Pantaleo, Dario De Biase, Giovanni Tallini
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
We are recently faced with a progressive evolution of the therapeutic paradigm for radioiodine refractory differentiated thyroid cancer (RAI-R DTC), since the advent of tissue agnostic inhibitors. Thus, tumor genotype assessment is always more releva
Externí odkaz:
https://doaj.org/article/49cd3f8164ad45bf8f469eaab1aeaaa6
Autor:
Costantino Ricci, Elisa Capizzi, Francesca Giunchi, Laura Casolari, Francesco Gelsomino, Karim Rihawi, Filippo Natali, Vanina Livi, Rocco Trisolini, Michelangelo Fiorentino, Andrea Ardizzoni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Introduction: Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assessment is mandatory for the single agent pembrolizumab treatment of patients with advanced non-small cell lung cancer (NSCLC). PD-L1 testing has been validated and is curr
Externí odkaz:
https://doaj.org/article/0e4de554e2c1485b8467227e5c5680aa
Autor:
Matteo Fontana, Roberto Tonelli, Filippo Gozzi, Ivana Castaniere, Alessandro Marchioni, Riccardo Fantini, Francesca Coppi, Filippo Natali, Elisabetta Rovatti, Enrico Clini
Publikováno v:
Multidisciplinary Respiratory Medicine, Vol 13, Iss 1, Pp 1-4 (2018)
Abstract Background Hemoptysis is a frequent sign of respiratory and non-respiratory diseases. While in most cases the underlying cause is rapidly identified, sometimes the real etiology might be misdiagnosed with dramatic delay in treatment. Case pr
Externí odkaz:
https://doaj.org/article/57deb90f98f44e74aea2c6f3a2d42370
Autor:
Marco Busutti, Alessandra Cingolani, Filippo Natali, Maria Mattiotti, Valeria Grandinetti, Olga Baraldi, Giorgia Comai, Piero Candoli, Gaetano La Manna
Publikováno v:
Journal of nephrology. 35(4)
Autor:
Giovanni Tallini, Alessandra Cancellieri, Filippo Natali, Andrea Ardizzoni, Elisa Capizzi, Rocco Trisolini, Dario de Biase, Michelangelo Fiorentino, Marco Ferrari, Daniela Paioli, Vanina Livi
Publikováno v:
The Clinical Respiratory Journal. 13:590-597
INTRODUCTION AND OBJECTIVES: Endosonography is increasingly used for the diagnosis of centrally located, bronchoscopically invisible intrapulmonary lesions, but data regarding its utility for molecular profiling are lacking. We aimed to assess the su
Autor:
Vanina Livi, Daniela Paioli, Marco Ferrari, Alessandra Cancellieri, Annalisa De Silvestri, Micaela Romagnoli, Rocco Trisolini, Filippo Natali, Carmine Tinelli
Publikováno v:
Respiration. 97:540-547
Background: The widespread use of rapid on-site evaluation is hampered by constraints related to time and resources, inadequate reimbursement, and evidence from randomized trials that show a lack of increase in diagnostic yield and specimen adequacy
Autor:
Michelangelo Fiorentino, Rocco Trisolini, Filippo Natali, Daniela Paioli, Alessandra Cancellieri, Sara Betti, Vanina Livi, Marco Ferrari
Background: Diagnosis, staging, and molecular profiling of lung cancer are mostly carried out with bronchoscopy or CT-guided aspiration/biopsy. However, patients with locally advanced or advanced disease often harbor “superficial” metastases for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57c2ac7371449feb3005766d68f72007
http://hdl.handle.net/11585/818487
http://hdl.handle.net/11585/818487
Autor:
Roel L J Verhoeven, Rocco Trisolini, Alessandra Cancellieri, Filippo Natali, Erik H.F.M. van der Heijden, Annalisa De Silvestri
Publikováno v:
Respirology, 25, 11, pp. 1203-1206
Respirology, 25, 1203-1206
Respirology, 25, 1203-1206
Contains fulltext : 229781.pdf (Publisher’s version ) (Closed access)
Autor:
Francesco Gelsomino, Elisa Capizzi, Vanina Livi, Laura Casolari, Michelangelo Fiorentino, Filippo Natali, Karim Rihawi, Rocco Trisolini, Andrea Ardizzoni, Costantino Ricci, Francesca Giunchi
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Introduction: Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assessment is mandatory for the single agent pembrolizumab treatment of patients with advanced non-small cell lung cancer (NSCLC). PD-L1 testing has been validated and is curr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a151c79968aaff3aac007a2c734ad75b
http://hdl.handle.net/11585/790651
http://hdl.handle.net/11585/790651
Autor:
Alessandra Cancellieri, Rocco Trisolini, Michelangelo Fiorentino, Daniela Paioli, Filippo Natali, Marco Ferrari, Jouke T. Annema, Andrea Ardizzoni, Annalisa Altimari, Vanina Livi, Nicole Conci
Publikováno v:
Lung cancer (Amsterdam, Netherlands), 147, 204-208. Elsevier Ireland Ltd
Introduction Pulmonary adenocarcinoma with psammoma bodies (PAPBs) is a rare histological variant whose association with a high prevalence of targetable mutations has been suggested by scant literature reports describing small series. We aim to descr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4181f8b808b14550baa6c3dc7dbad0b
http://hdl.handle.net/11585/767849
http://hdl.handle.net/11585/767849